Remarkably, patients with active IBD have functionally distinct microbiota-reactive CD4+ T cells, compared with those found in healthy controls, and secrete higher levels of IL-17 (14, 26, 28–30, 67). Here, IL17A is linked to inflammatory bowel disease.